CN103585456A - Sea cucumber chewable tablet - Google Patents
Sea cucumber chewable tablet Download PDFInfo
- Publication number
- CN103585456A CN103585456A CN201310491365.4A CN201310491365A CN103585456A CN 103585456 A CN103585456 A CN 103585456A CN 201310491365 A CN201310491365 A CN 201310491365A CN 103585456 A CN103585456 A CN 103585456A
- Authority
- CN
- China
- Prior art keywords
- parts
- stichopus japonicus
- rhizoma
- radix
- chewable tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 21
- 229940068682 chewable tablet Drugs 0.000 title claims abstract description 21
- 241000251511 Holothuroidea Species 0.000 title abstract description 30
- 239000000463 material Substances 0.000 claims abstract description 24
- 229920001353 Dextrin Polymers 0.000 claims abstract description 20
- 239000004375 Dextrin Substances 0.000 claims abstract description 20
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 20
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 20
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 20
- 235000019425 dextrin Nutrition 0.000 claims abstract description 20
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 20
- 229920002472 Starch Polymers 0.000 claims abstract description 19
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 19
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 19
- 239000008107 starch Substances 0.000 claims abstract description 19
- 235000019698 starch Nutrition 0.000 claims abstract description 19
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 18
- 229930195725 Mannitol Natural products 0.000 claims abstract description 18
- 239000000594 mannitol Substances 0.000 claims abstract description 18
- 235000010355 mannitol Nutrition 0.000 claims abstract description 18
- 241000965254 Apostichopus japonicus Species 0.000 claims description 85
- 229920002101 Chitin Polymers 0.000 claims description 29
- 241000628997 Flos Species 0.000 claims description 19
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 19
- 241000180649 Panax notoginseng Species 0.000 claims description 19
- 239000009286 sanguis draxonis Substances 0.000 claims description 19
- 235000013599 spices Nutrition 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 16
- 239000003814 drug Substances 0.000 abstract description 19
- 230000035876 healing Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000033228 biological regulation Effects 0.000 abstract description 2
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 229920001661 Chitosan Polymers 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 235000000525 Dimocarpus longan Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 235000017276 Salvia Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 55
- 239000000843 powder Substances 0.000 description 34
- 206010052428 Wound Diseases 0.000 description 32
- 208000027418 Wounds and injury Diseases 0.000 description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 239000004365 Protease Substances 0.000 description 24
- 230000029663 wound healing Effects 0.000 description 24
- 239000000706 filtrate Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 239000000203 mixture Substances 0.000 description 18
- 108091005804 Peptidases Proteins 0.000 description 16
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 16
- 235000019419 proteases Nutrition 0.000 description 16
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000000284 extract Substances 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 12
- 230000002255 enzymatic effect Effects 0.000 description 12
- 239000011347 resin Substances 0.000 description 12
- 229920005989 resin Polymers 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 238000012545 processing Methods 0.000 description 9
- 108010004032 Bromelains Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 235000019835 bromelain Nutrition 0.000 description 8
- 238000010828 elution Methods 0.000 description 8
- 238000004108 freeze drying Methods 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 102100032742 Histone-lysine N-methyltransferase SETD2 Human genes 0.000 description 7
- 101000654725 Homo sapiens Histone-lysine N-methyltransferase SETD2 Proteins 0.000 description 7
- 230000035611 feeding Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 6
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 206010063560 Excessive granulation tissue Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
- 230000003187 abdominal effect Effects 0.000 description 4
- 230000000274 adsorptive effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000000748 compression moulding Methods 0.000 description 4
- 230000009849 deactivation Effects 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 230000000857 drug effect Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 238000011010 flushing procedure Methods 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 210000001126 granulation tissue Anatomy 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 239000007952 growth promoter Substances 0.000 description 4
- 238000005213 imbibition Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000001728 nano-filtration Methods 0.000 description 4
- 235000011837 pasties Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 230000002000 scavenging effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- -1 10 parts Polymers 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 3
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 3
- 244000111489 Gardenia augusta Species 0.000 description 3
- 102000016878 Hypoxia-Inducible Factor 1 Human genes 0.000 description 3
- 108010028501 Hypoxia-Inducible Factor 1 Proteins 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229960003080 taurine Drugs 0.000 description 3
- 230000003867 tiredness Effects 0.000 description 3
- 208000016255 tiredness Diseases 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 229930188089 Holothurin Natural products 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 102000013275 Somatomedins Human genes 0.000 description 2
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 2
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 235000004213 low-fat Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000007442 rickets Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003556 vascular endothelial cell Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000000592 Artificial Cell Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000010970 Connexin Human genes 0.000 description 1
- 108050001175 Connexin Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102100033902 Endothelin-1 Human genes 0.000 description 1
- 101800004490 Endothelin-1 Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- 208000032594 Vascular Remodeling Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000022972 amelogenesis Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000013860 dentinogenesis Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- MAWWITJOQDJRJF-ADBICINLSA-M holothurin Chemical compound [Na+].O[C@@H]1[C@@H](OC)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@H]([C@@H]3O)OS([O-])(=O)=O)O[C@@H]3C([C@H]4[C@](C=5[C@H]([C@@]6(CC[C@]7(O)[C@](C)([C@H]8OC(C)(C)CC8)OC(=O)[C@@]76[C@@H](O)C=5)C)CC4)(C)CC3)(C)C)O[C@@H]2C)O)O[C@H](C)[C@H]1O MAWWITJOQDJRJF-ADBICINLSA-M 0.000 description 1
- 229930186900 holotoxin Natural products 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- SQFDQLBYJKFDDO-UHFFFAOYSA-K merbromin Chemical compound [Na+].[Na+].C=12C=C(Br)C(=O)C=C2OC=2C([Hg]O)=C([O-])C(Br)=CC=2C=1C1=CC=CC=C1C([O-])=O SQFDQLBYJKFDDO-UHFFFAOYSA-K 0.000 description 1
- 229940008716 mercurochrome Drugs 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000031864 metaphase Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000009702 powder compression Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 231100001055 skeletal defect Toxicity 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a sea cucumber chewable tablet which comprises the following active components proportioned in parts by weight: traditional Chinese medicine materials: 30 to 50 parts of bletilla striata, 20 to 40 parts of cacumen biotae, 20 to 40 parts of folium artemisiae argyi, 20 to 40 parts of the root of red-rooted salvia, 10 to 30 parts of sangusis draconis, 10 to 30 parts of white atractylodes rhizome, 10 to 30 parts of dimocarpus longan, 10 to 30 parts of dried rehamnnia root, 10 to 30 parts of wild chrysanthemum flower, 10 to 30 parts of golden cypress, 10 to 30 parts of pseudo-ginseng, 10 to 30 parts of polygonum cuspidatum, 10 to 30 parts of pericarpium citri reticulatae viride, 10 to 30 parts of fructus gardeniae; a base material comprising 300 to 500 parts of sea cucumbers; auxiliary materials comprising 3 to 6 parts of chitosan, 10 to 20 parts of starch, 5 to 10 parts of dextrin, 3 to 6 parts of mannitol, 1 to 4 parts of sweetening agent and 1 to 4 parts of microcrystalline cellulose. The sea cucumber chewable tablet is simple in proportioning and reasonable in formula matching, and is used for promoting immunization regulation and accelerating the healing speed of a wound.
Description
technical field:
The present invention relates to Stichopus japonicus deep process technology field, relate in particular to a kind of Stichopus japonicus chewable tablet.
background technology:
Stichopus japonicus is extremely low containing cholesterol, is a kind of typical high protein, low fat, low cholesterol food.Add its fine and tender taste, be easy to digestion, so, be suitable for very much old people, child and the people that has a delicate constitution edible.Stichopus japonicus, because of extremely low containing cholesterol, is the food of a kind of typical high protein, low fat, low cholesterol.Because of fine and tender taste, be easy to digestion again, thus be applicable to very much old people and child, and the person of having a delicate constitution is edible.Taurine in Stichopus japonicus, nicotinic acid etc.; there is nervous system regulation, quick allaying tiredness; the effect of prevention skin aging; the taurine containing in Stichopus japonicus in addition, lysine, methionine etc. almost do not have in vegetable food; the chondroitin sulfate containing in Radix Morinae Bulleyanae and Radix Morinae Bulleyanae mucopolysaccharide; by pharmacological evaluation, prove, to the growth promoter of human body, antiinflammatory skeletonization and prevention failure, promoting wound healing to suppress several cancerous cell has special efficacy.Continuity is old and feeble, allaying tiredness, improve immunity, the natural precious active substances of kind more than 50 such as the ability Stichopus japonicus rich in proteins of enhancing resist the disease, mineral, vitamin, wherein acid mucopolysaccharide and chrondroitin can obviously reduce the quantity of lipofuscin and skin proline in heart tissue, play the effect of slow down aging.In Stichopus japonicus body, 18 contained seed amino acids can strengthen the metabolic function of tissue, and enhancing body cell viability, is suitable for the teenager in growth promoter.Stichopus japonicus energy balance the body water balance, is suitable for the Ms of pregnancy period legs and feet edema.Stichopus japonicus energy allaying tiredness, improves body immunity, strengthens the ability of human body resist the disease, is therefore applicable to very much often middle aged Ms and the man in fatigue state, the sub-health populations such as easy catching a cold, the old people who has a delicate constitution and child.
Other functions of Stichopus japonicus, as eliminated tumor, the anticancer heart that protects: contain a large amount of holothurins in the tissues such as body wall, internal organs and body of gland of Stichopus japonicus, be again holotoxin.Holothurin is a kind of counterpoison, nontoxic to human-body safety, but growth and the transfer of energy inhibition tumor cell, effectively anti-cancer, anticancer, has been widely used in the treatment of hepatocarcinoma, pulmonary carcinoma, gastric cancer, nasopharyngeal carcinoma, osteocarcinoma, lymphatic cancer, ovarian cancer, uterus carcinoma, breast carcinoma, brain cancer leukemia and hands postoperative patient clinically.Improve the frequent beche-de-mer of osteoporosis and can prevent child's rickets, adult's osteoporosis and bone matrix hyperplasia.In gold most distinguished Stichopus japonicus, the element such as abundant calcium, phosphorus, manganese, copper, germanium, silicon is to prevention Infant Rickets, adult's osteoporosis and to skeletal abnormality, deformity, and dentine and enamel development be bad special role.Enhancing development beche-de-mer helps lend some impetus to growth promoter.Abundant arginine, lysine, taurine, calcium, phosphorus, iodine, ferrum, zinc in Stichopus japonicus; it is the important substance that human development grows up; they participate in the physiological activity such as growth promoter, immune regulation, wound healing, reproductive development of human body itself directly; in body energy deposit and running, play an important role; therefore; as postoperative nutriment, Stichopus japonicus can be accelerated the healing rate of wound greatly.
In daily life and medical treatment, wound can hardly be avoided, as wound, operation etc. all can cause certain wound.Due to the situation of wound healing and the development of the state of an illness closely related, therefore wound healing becomes one of focus important in medical research now.In recent years, Chinese herbal medicine is subject to people's favor gradually, and Chinese medicine is just in healthy and strong development, and the research of Chinese herbal medicine supporting wound healing also continues to bring out.Now just to Chinese herbal medicine, promote the effects anb Mechanism of wound healing to be summarized as follows.The traditional Chinese medical science is wanted > > to note to the understanding < < roman class of wound healing to say: " limbs damage in outside, QI and blood is hindered in interior, battalion defends to some extent does not pass through, internal organs by discord." point out after body wound QI and blood lose support, battalion defending to become estranged and causing that coagulation of QI-blood, meridians block, visceral dysfunction.The qi and blood prosperity and decline of wound surface, battalion's strong defensive QI are weak most important to the healing of wound surface, therefore blood circulation promoting and blood stasis dispelling, promoting of the circulation of QI and removing the obstruction in the collaterals are the keys for the treatment of wound.Chinese medicine thinks, wound is caused by exopathogenic factor, and " wound " is more shallow at skin surface, degree, and " wound " refers to the infringement that metal sharp sword causes, the deep muscle that reaches.No matter which kind of wound, all can injure blood network, vascular, occurs hemorrhage, blood stasis or hematoma, and stopping blooding, subsiding a swelling, invigorate blood circulation is the requisite step for the treatment of wound.Chinese medicine promotes the growth of wound surface granulation tissue mainly to concentrate on the aspects such as putrefaction-removing granulation-promoting, expelling the stasis for the new and tonification granulation promoting.
Stichopus japonicus has remarkable result for promotion wound healing, so, usually used as the nutritional supplement after postoperative or wound.The instructions of taking of Stichopus japonicus, still take tonic as main at present, and tonic causes human absorptivity not enough, and the taboo of some culinary arts also usually causes the loss of sea cucumber nutrient composition, as, Stichopus japonicus can not be cooked flavoring agent with vinegar.Therefore, there are on the market some Stichopus japonicus deep processed products, as oral liquid, tablet, capsule, honey refining pill etc., in the process of deep processing, often adds Chinese patent medicine to improve the absorbance of product or to increase other auxiliary functions, but, some formula is unreasonable, for example, Stichopus japonicus can not with Radix Glycyrrhizae compatibility etc.Therefore, it is simple that the present invention aims to provide a kind of proportioning, and rationally, a kind of Stichopus japonicus chewable tablet of speed of wound healing is reconciled, increased to Promote immunity in prescription collocation.
summary of the invention:
The object of the invention is to overcome the shortcoming existing in prior art, provide a kind of proportioning simple, rationally, a kind of Stichopus japonicus chewable tablet of speed of wound healing is reconciled, increased to Promote immunity in prescription collocation.
To achieve these goals, the invention provides a kind of Stichopus japonicus chewable tablet, wherein, comprise according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 30-50 part, Cacumen Platycladi 20-40 part, Folium Artemisiae Argyi 20-40 part, Radix Salviae Miltiorrhizae 20-40 part, Sanguis Draxonis 10-30 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Arillus Longan 10-30 part, Radix Rehmanniae 10-30 part, Flos Chrysanthemi Indici 10-30 part, Cortex Phellodendri 10-30 part, Radix Notoginseng 10-30 part, Rhizoma Polygoni Cuspidati 10-30 part, Pericarpium Citri Reticulatae Viride 10-30 part, Fructus Gardeniae 10-30 part
Basestocks: Stichopus japonicus 300-500 part;
Additional material: chitin 3-6 part, starch 10-20 part, dextrin 5-10 part, mannitol 3-6 part, sweeting agent 1-4 part, microcrystalline Cellulose 1-4 part.
Or, comprise according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 30-40 part, Cacumen Platycladi 20-30 part, Folium Artemisiae Argyi 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Sanguis Draxonis 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Arillus Longan 10-20 part, Radix Rehmanniae 10-20 part, Flos Chrysanthemi Indici 10-20 part, Cortex Phellodendri 10-20 part, Radix Notoginseng 10-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Pericarpium Citri Reticulatae Viride 10-20 part, Fructus Gardeniae 10-20 part
Basestocks: Stichopus japonicus 300-400 part;
Additional material: chitin 3-5 part, starch 10-15 part, dextrin 5-8 part, mannitol 3-5 part, sweeting agent 1-3 part, microcrystalline Cellulose 1-3 part.
Or, comprise according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 40-50 part, Cacumen Platycladi 30-40 part, Folium Artemisiae Argyi 30-40 part, Radix Salviae Miltiorrhizae 30-40 part, Sanguis Draxonis 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Arillus Longan 20-30 part, Radix Rehmanniae 20-30 part, Flos Chrysanthemi Indici 20-30 part, Cortex Phellodendri 20-30 part, Radix Notoginseng 20-30 part, Rhizoma Polygoni Cuspidati 20-30 part, Pericarpium Citri Reticulatae Viride 20-30 part, Fructus Gardeniae 20-30 part
Basestocks: Stichopus japonicus 400-500 part;
Additional material: chitin 4-6 part, starch 15-20 part, dextrin 8-10 part, mannitol 4-6 part, sweeting agent 2-4 part, microcrystalline Cellulose 2-4 part.
Or, comprise according to the following active component of parts by weight configuration:
Middle spice: middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 35-45 part, Cacumen Platycladi 25-35 part, Folium Artemisiae Argyi 25-35 part, Radix Salviae Miltiorrhizae 25-35 part, Sanguis Draxonis 15-25 part, Rhizoma Atractylodis Macrocephalae 15-25 part, Arillus Longan 15-25 part, Radix Rehmanniae 15-25 part, Flos Chrysanthemi Indici 15-25 part, Cortex Phellodendri 15-25 part, Radix Notoginseng 15-25 part, Rhizoma Polygoni Cuspidati 15-25 part, Pericarpium Citri Reticulatae Viride 15-25 part, Fructus Gardeniae 15-25 part
Basestocks: Stichopus japonicus 350-450 part;
Additional material: chitin 4-5 part, starch 12-18 part, dextrin 6-9 part, mannitol 2-5 part, sweeting agent 2-3 part, microcrystalline Cellulose 2-3 part.
Object to better implement the present invention, the present invention discloses again the preparation method of Stichopus japonicus chewable tablet, wherein, comprises the steps:
The step of A, cleaning: by the Pseudobulbus Bletillae (Rhizoma Bletillae), Cacumen Platycladi, Folium Artemisiae Argyi, Radix Salviae Miltiorrhizae, Sanguis Draxonis, the Rhizoma Atractylodis Macrocephalae, Arillus Longan, Radix Rehmanniae, Flos Chrysanthemi Indici, Cortex Phellodendri, Radix Notoginseng, Rhizoma Polygoni Cuspidati, Pericarpium Citri Reticulatae Viride, Fructus Gardeniae, is used tumbling-box type medicine-washing machine to clean, and scavenging period is controlled at 3-5 minute, avoids drug effect to run off;
The step of B, demulcen: the Chinese medicinal components that steps A is cleaned up, use water injection type medicine processing device to carry out demulcen operation, demulcen makes the plant cell imbibition of dehydration, for abstraction process creates conditions;
C, above-mentioned component add 10 times of weight amount ethanol, heating and refluxing extraction 3 times, and each 2 hours, 3 extracting solution are merged, decompression recycling ethanol, and to be concentrated into liquor strength be 0.5g crude drug/mL, after sucking filtration, when the relative density of filtrate is 20 ℃ 1.08; The macroporous adsorptive resins that described filtrate flow is 10L through volume, use afterwards deionized water or the distilled water eluting of 10 times of resin column volumes, use again 95% ethanol elution of 5 times of resin column volumes, collect ethanol elution, remove alcohol solvent, obtain Chinese medicinal powder, then after 80 order sieve, standby after ultraviolet sterilization;
The step of D, Stichopus japonicus deep processing: fresh and alive sea cucumbers, along abdominal part from first to last complete section open, gill, impurity is cleaned up; Then carry out lyophilization, cryogenic temperature is-20 ~-25 ℃, and vacuum is 5-15Pa, and quick freezing 2-3h puts into pulverizer by the Stichopus japonicus after lyophilization, pulverizes 10-30min, crosses 60 mesh sieves, obtains thick Stichopus japonicus powder; Stichopus japonicus coarse powder is carried out to micronizing by jet mill, and time 2-3h, obtains ultra micro Stichopus japonicus powder; Then ultra micro Stichopus japonicus powder is carried out to nanorize pulverizing by high speed shear ultrafine crusher, grinding time is 3-5h;
In container, add pure water, Stichopus japonicus powder after nanorize is pulverized with water with 1: the dissolving of 5-10 mass ratio, obtain sea cucumber milk, take the compound protease of Stichopus japonicus weight 0.3-0.4%, compound protease is the mixture of pepsic bromelain stomach, protease: the mass ratio=2:1 of bromelain, after using pure water that compound protease is dissolved, together with sea cucumber milk, put into enzymatic vessel, standing 1-2min in the microwave environment that is 500-1000w in intensity, carry out the operation of microwave enzymolysis, after enzymolysis completes, by enzymolysis solution rapidly degree of intensification to 90 ℃ of enzyme denaturing 10-30min, complete after the deactivation of enzyme, enzymatic vessel is stopped to heating, enzymolysis solution is cooled to rapidly to room temperature, enzymatic vessel purified rinse water, flushing liquor is put into enzymolysis solution, enzymolysis solution after cooling is first used to the centrifugal 20min of generic centrifuge, filter, get filtrate, the centrifugal 20min of low temperature ultrahigh speed, filters, and obtains filtrate, by filtrate by nanofiltration with except freshen, residue is crossed 100 mesh sieves, obtains sea cucumber extract,
E, prepare the step of capsule: step C gained Chinese medicinal powder is joined in the sea cucumber extract of step D gained to Chinese medicinal powder: the weight ratio of sea cucumber extract is 1-1.2:1-1.5; After mix homogeneously, add additional material, in the pasty state, compression molding, is dried to obtain chewable tablet to the mixture obtaining.
Composition in additional material is as follows:
The medical knowledge effect of chitin (being chitin) is as follows: 1, trauma hemostasis, the chitin of platelet in blood is combined, and can improve the adhesion of wound tissue, makes fast local vascular shrink, and reduces hemorrhage quantity.2, improve speed of wound healing, the basic substance of volume is badly in need of in new histiocytic propagation, formation, and hyaluronic acid is important material.Carapace mass-energy increases hyaluronic quantity in tissue, promotes the formation of cell membrane.And in activating cell process, produce a large amount of collagen fiber, and form rapidly compact substance skin, can scar.3, chitin can be prevented and treated wound face and infects, and chitin is used in wound part outward can bacteria growing inhibiting, and domestic and foreign literature report chitin applies wound in vitro can suppress gram positive bacteria and Candida albicans growth, and 5 mg/ml bacteriostasis rates reach 75 ~ 100%; Can increase the local cytophagous quantity of wound and activity; Eliminate in time slough, promote the formation of granulation tissue.This three large key element that forms wound wound healing, complements each other and comprehensively works.4, the application of chitin on Orthopeadic Surgery, chitin is as the damaged portion of bone implant, owing to helping platelet adhesion to accelerate coagulation, show good anastalsis, at chitinous phagocyte, the macrophage of assembling volume around, the invasion and attack that suppress local pathogen have the effect that obvious accelerated bone is repaired.
Starch: relatively more conventional is corn starch, its character is highly stable, inoperative with most drug, price is also more cheap, and hygroscopicity is little, appearance luster good, in actual production, often mix use with the good Icing Sugar of compressibility, dextrin, this is because the compressibility of starch is poor, if use separately, can make the tablet of extrusion too loose.
Dextrin: dextrin is the general name of Starch Hydrolysis intermediate product, its chemical formula is (C6H10O5) nXH2O, its hydrotrope is about 80%, dissolves slowlyer in cold water, is soluble in hot water, is insoluble to ethanol.Also be called traditionally as height and stick with paste (high viscosity dextrin), there is stronger caking property.
Microcrystalline Cellulose: microcrystalline Cellulose (Microcrystalline cellulose, MCC) be cellulose partial hydrolysis and the less crystallinity cellulose of the degree of polymerization that makes, there is good compressibility, there is stronger adhesion, the tablet being pressed into has more greatly hardness, and " dry adhesives " that can be used as direct powder compression used.
Mannitol: mannitol is granule or Powdered, heat absorption when orally-dissolvable, thereby have cooling feeling, and have certain sweet taste concurrently simultaneously, in mouth, without sand type, therefore be suitable for preparing chewable tablet.
Sweeting agent (preferably Icing Sugar): Icing Sugar means the white powder that crystallinity sucrose forms after cold drying is pulverized, and its advantage is that bonding force is strong, can be used to increase the hardness of tablet, and makes the smooth surface of tablet attractive in appearance.
Advantage of the present invention is: proportioning is simple, and rationally, Promote immunity is reconciled, increased speed of wound healing, is specially in prescription collocation:
The present invention be take Stichopus japonicus as basestocks, add therein blood circulation promoting and blood stasis dispelling, hemostasis and pain-relieving, promoting of the circulation of QI and removing the obstruction in the collaterals, the corresponding Chinese medicinal components of clearing heat and moistening dryness, to improve speed of wound healing, in addition, further add chitin, Stichopus japonicus effect, herbal function are combined with chitin effect, preparation becomes chewable tablet to be used, and all effect is remarkable in the speed for the treatment of wound for more independent treatment by Chinese herbs, simple Stichopus japonicus tonic or chitin soft gelatin capsule.
the specific embodiment:
Stichopus japonicus chewable tablet, wherein, comprises according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 30-50 part, Cacumen Platycladi 20-40 part, Folium Artemisiae Argyi 20-40 part, Radix Salviae Miltiorrhizae 20-40 part, Sanguis Draxonis 10-30 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Arillus Longan 10-30 part, Radix Rehmanniae 10-30 part, Flos Chrysanthemi Indici 10-30 part, Cortex Phellodendri 10-30 part, Radix Notoginseng 10-30 part, Rhizoma Polygoni Cuspidati 10-30 part, Pericarpium Citri Reticulatae Viride 10-30 part, Fructus Gardeniae 10-30 part
Basestocks: Stichopus japonicus 300-500 part;
Additional material: chitin 3-6 part, starch 10-20 part, dextrin 5-10 part, mannitol 3-6 part, sweeting agent 1-4 part, microcrystalline Cellulose 1-4 part.
Or, comprise according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 30-40 part, Cacumen Platycladi 20-30 part, Folium Artemisiae Argyi 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Sanguis Draxonis 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Arillus Longan 10-20 part, Radix Rehmanniae 10-20 part, Flos Chrysanthemi Indici 10-20 part, Cortex Phellodendri 10-20 part, Radix Notoginseng 10-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Pericarpium Citri Reticulatae Viride 10-20 part, Fructus Gardeniae 10-20 part
Basestocks: Stichopus japonicus 300-400 part;
Additional material: chitin 3-5 part, starch 10-15 part, dextrin 5-8 part, mannitol 3-5 part, sweeting agent 1-3 part, microcrystalline Cellulose 1-3 part.
Or, comprise according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 40-50 part, Cacumen Platycladi 30-40 part, Folium Artemisiae Argyi 30-40 part, Radix Salviae Miltiorrhizae 30-40 part, Sanguis Draxonis 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Arillus Longan 20-30 part, Radix Rehmanniae 20-30 part, Flos Chrysanthemi Indici 20-30 part, Cortex Phellodendri 20-30 part, Radix Notoginseng 20-30 part, Rhizoma Polygoni Cuspidati 20-30 part, Pericarpium Citri Reticulatae Viride 20-30 part, Fructus Gardeniae 20-30 part
Basestocks: Stichopus japonicus 400-500 part;
Additional material: chitin 4-6 part, starch 15-20 part, dextrin 8-10 part, mannitol 4-6 part, sweeting agent 2-4 part, microcrystalline Cellulose 2-4 part.
Or, comprise according to the following active component of parts by weight configuration:
Middle spice: middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 35-45 part, Cacumen Platycladi 25-35 part, Folium Artemisiae Argyi 25-35 part, Radix Salviae Miltiorrhizae 25-35 part, Sanguis Draxonis 15-25 part, Rhizoma Atractylodis Macrocephalae 15-25 part, Arillus Longan 15-25 part, Radix Rehmanniae 15-25 part, Flos Chrysanthemi Indici 15-25 part, Cortex Phellodendri 15-25 part, Radix Notoginseng 15-25 part, Rhizoma Polygoni Cuspidati 15-25 part, Pericarpium Citri Reticulatae Viride 15-25 part, Fructus Gardeniae 15-25 part
Basestocks: Stichopus japonicus 350-450 part;
Additional material: chitin 4-5 part, starch 12-18 part, dextrin 6-9 part, mannitol 2-5 part, sweeting agent 2-3 part, microcrystalline Cellulose 2-3 part.
Object lesson 1
Middle spice: 50 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 40 parts of Cacumen Platycladis, 40 parts of Folium Artemisiae Argyis, 40 parts of Radix Salviae Miltiorrhizaes, 30 parts of Sanguis Draxonis, 30 parts of the Rhizoma Atractylodis Macrocephalaes, 30 parts of Arillus Longans, 30 parts of Radix Rehmanniae, 30 parts of Flos Chrysanthemi Indicis, 30 parts of Cortex Phellodendris, 30 parts of Radix Notoginseng, 30 parts of Rhizoma Polygoni Cuspidati, 30 parts, Pericarpium Citri Reticulatae Viride, 30 parts of Fructus Gardeniaes,
Basestocks: 500 parts of Stichopus japonicuss;
Additional material: 6 parts of chitins, 20 parts of starch, 10 parts, dextrin, 6 parts, mannitol, 4 parts of sweeting agents, 4 parts of microcrystalline Cellulose.
During preparation, the step of A, cleaning: by the Pseudobulbus Bletillae (Rhizoma Bletillae), Cacumen Platycladi, Folium Artemisiae Argyi, Radix Salviae Miltiorrhizae, Sanguis Draxonis, the Rhizoma Atractylodis Macrocephalae, Arillus Longan, Radix Rehmanniae, Flos Chrysanthemi Indici, Cortex Phellodendri, Radix Notoginseng, Rhizoma Polygoni Cuspidati, Pericarpium Citri Reticulatae Viride, Fructus Gardeniae, is used tumbling-box type medicine-washing machine to clean, and scavenging period is controlled at 3-5 minute, avoids drug effect to run off;
The step of B, demulcen: the Chinese medicinal components that steps A is cleaned up, use water injection type medicine processing device to carry out demulcen operation, demulcen makes the plant cell imbibition of dehydration, for abstraction process creates conditions;
C, above-mentioned component add 10 times of weight amount ethanol, heating and refluxing extraction 3 times, and each 2 hours, 3 extracting solution are merged, decompression recycling ethanol, and to be concentrated into liquor strength be 0.5g crude drug/mL, after sucking filtration, when the relative density of filtrate is 20 ℃ 1.08; The macroporous adsorptive resins that described filtrate flow is 10L through volume, use afterwards deionized water or the distilled water eluting of 10 times of resin column volumes, use again 95% ethanol elution of 5 times of resin column volumes, collect ethanol elution, remove alcohol solvent, obtain Chinese medicinal powder, then after 80 order sieve, standby after ultraviolet sterilization;
The step of D, Stichopus japonicus deep processing: fresh and alive sea cucumbers, along abdominal part from first to last complete section open, gill, impurity is cleaned up; Then carry out lyophilization, cryogenic temperature is-20 ~-25 ℃, and vacuum is 5-15Pa, and quick freezing 2-3h puts into pulverizer by the Stichopus japonicus after lyophilization, pulverizes 10-30min, crosses 60 mesh sieves, obtains thick Stichopus japonicus powder; Stichopus japonicus coarse powder is carried out to micronizing by jet mill, and time 2-3h, obtains ultra micro Stichopus japonicus powder; Then ultra micro Stichopus japonicus powder is carried out to nanorize pulverizing by high speed shear ultrafine crusher, grinding time is 3-5h;
In container, add pure water, Stichopus japonicus powder after nanorize is pulverized with water with 1: the dissolving of 5-10 mass ratio, obtain sea cucumber milk, take the compound protease of Stichopus japonicus weight 0.3-0.4%, compound protease is the mixture of pepsic bromelain stomach, protease: the mass ratio=2:1 of bromelain, after using pure water that compound protease is dissolved, together with sea cucumber milk, put into enzymatic vessel, standing 1-2min in the microwave environment that is 500-1000w in intensity, carry out the operation of microwave enzymolysis, after enzymolysis completes, by enzymolysis solution rapidly degree of intensification to 90 ℃ of enzyme denaturing 10-30min, complete after the deactivation of enzyme, enzymatic vessel is stopped to heating, enzymolysis solution is cooled to rapidly to room temperature, enzymatic vessel purified rinse water, flushing liquor is put into enzymolysis solution, enzymolysis solution after cooling is first used to the centrifugal 20min of generic centrifuge, filter, get filtrate, the centrifugal 20min of low temperature ultrahigh speed, filters, and obtains filtrate, by filtrate by nanofiltration with except freshen, residue is crossed 100 mesh sieves, obtains sea cucumber extract,
E, prepare the step of capsule: step C gained Chinese medicinal powder is joined in the sea cucumber extract of step D gained to Chinese medicinal powder: the weight ratio of sea cucumber extract is 1-1.2:1-1.5; After mix homogeneously, add additional material, in the pasty state, compression molding, is dried to obtain chewable tablet to the mixture obtaining.
Object lesson 2
Middle spice: 30 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 20 parts of Cacumen Platycladis, 20 parts of Folium Artemisiae Argyis, 20 parts of Radix Salviae Miltiorrhizaes, 10 parts of Sanguis Draxonis, 10 parts of the Rhizoma Atractylodis Macrocephalaes, 10 parts of Arillus Longans, 10 parts of Radix Rehmanniae, 10 parts of Flos Chrysanthemi Indicis, 10 parts of Cortex Phellodendris, 10 parts of Radix Notoginseng, 10 parts of Rhizoma Polygoni Cuspidati, 10 parts, Pericarpium Citri Reticulatae Viride, 10 parts of Fructus Gardeniaes,
Basestocks: 300 parts of Stichopus japonicuss;
Additional material: 3 parts of chitins, 10 parts of starch, 5 parts, dextrin, 3 parts, mannitol, 1 part of sweeting agent, 1 part of microcrystalline Cellulose.
During preparation, the step of A, cleaning: by the Pseudobulbus Bletillae (Rhizoma Bletillae), Cacumen Platycladi, Folium Artemisiae Argyi, Radix Salviae Miltiorrhizae, Sanguis Draxonis, the Rhizoma Atractylodis Macrocephalae, Arillus Longan, Radix Rehmanniae, Flos Chrysanthemi Indici, Cortex Phellodendri, Radix Notoginseng, Rhizoma Polygoni Cuspidati, Pericarpium Citri Reticulatae Viride, Fructus Gardeniae, is used tumbling-box type medicine-washing machine to clean, and scavenging period is controlled at 3-5 minute, avoids drug effect to run off;
The step of B, demulcen: the Chinese medicinal components that steps A is cleaned up, use water injection type medicine processing device to carry out demulcen operation, demulcen makes the plant cell imbibition of dehydration, for abstraction process creates conditions;
C, above-mentioned component add 10 times of weight amount ethanol, heating and refluxing extraction 3 times, and each 2 hours, 3 extracting solution are merged, decompression recycling ethanol, and to be concentrated into liquor strength be 0.5g crude drug/mL, after sucking filtration, when the relative density of filtrate is 20 ℃ 1.08; The macroporous adsorptive resins that described filtrate flow is 10L through volume, use afterwards deionized water or the distilled water eluting of 10 times of resin column volumes, use again 95% ethanol elution of 5 times of resin column volumes, collect ethanol elution, remove alcohol solvent, obtain Chinese medicinal powder, then after 80 order sieve, standby after ultraviolet sterilization;
The step of D, Stichopus japonicus deep processing: fresh and alive sea cucumbers, along abdominal part from first to last complete section open, gill, impurity is cleaned up; Then carry out lyophilization, cryogenic temperature is-20 ~-25 ℃, and vacuum is 5-15Pa, and quick freezing 2-3h puts into pulverizer by the Stichopus japonicus after lyophilization, pulverizes 10-30min, crosses 60 mesh sieves, obtains thick Stichopus japonicus powder; Stichopus japonicus coarse powder is carried out to micronizing by jet mill, and time 2-3h, obtains ultra micro Stichopus japonicus powder; Then ultra micro Stichopus japonicus powder is carried out to nanorize pulverizing by high speed shear ultrafine crusher, grinding time is 3-5h;
In container, add pure water, Stichopus japonicus powder after nanorize is pulverized with water with 1: the dissolving of 5-10 mass ratio, obtain sea cucumber milk, take the compound protease of Stichopus japonicus weight 0.3-0.4%, compound protease is the mixture of pepsic bromelain stomach, protease: the mass ratio=2:1 of bromelain, after using pure water that compound protease is dissolved, together with sea cucumber milk, put into enzymatic vessel, standing 1-2min in the microwave environment that is 500-1000w in intensity, carry out the operation of microwave enzymolysis, after enzymolysis completes, by enzymolysis solution rapidly degree of intensification to 90 ℃ of enzyme denaturing 10-30min, complete after the deactivation of enzyme, enzymatic vessel is stopped to heating, enzymolysis solution is cooled to rapidly to room temperature, enzymatic vessel purified rinse water, flushing liquor is put into enzymolysis solution, enzymolysis solution after cooling is first used to the centrifugal 20min of generic centrifuge, filter, get filtrate, the centrifugal 20min of low temperature ultrahigh speed, filters, and obtains filtrate, by filtrate by nanofiltration with except freshen, residue is crossed 100 mesh sieves, obtains sea cucumber extract,
E, prepare the step of capsule: step C gained Chinese medicinal powder is joined in the sea cucumber extract of step D gained to Chinese medicinal powder: the weight ratio of sea cucumber extract is 1-1.2:1-1.5; After mix homogeneously, add additional material, in the pasty state, compression molding, is dried to obtain chewable tablet to the mixture obtaining.
Object lesson 3
Middle spice: 40 parts of the Pseudobulbus Bletillae (Rhizoma Bletillae)s, 30 parts of Cacumen Platycladis, 30 parts of Folium Artemisiae Argyis, 30 parts of Radix Salviae Miltiorrhizaes, 20 parts of Sanguis Draxonis, 20 parts of the Rhizoma Atractylodis Macrocephalaes, 20 parts of Arillus Longans, 20 parts of Radix Rehmanniae, 20 parts of Flos Chrysanthemi Indicis, 20 parts of Cortex Phellodendris, 20 parts of Radix Notoginseng, 20 parts of Rhizoma Polygoni Cuspidati, 20 parts, Pericarpium Citri Reticulatae Viride, 20 parts of Fructus Gardeniaes,
Basestocks: 400 parts of Stichopus japonicuss;
Additional material: 5 parts of chitins, 15 parts of starch, 8 parts, dextrin, 5 parts, mannitol, 3 parts of sweeting agents, 3 parts of microcrystalline Cellulose.
During preparation, the step of A, cleaning: by the Pseudobulbus Bletillae (Rhizoma Bletillae), Cacumen Platycladi, Folium Artemisiae Argyi, Radix Salviae Miltiorrhizae, Sanguis Draxonis, the Rhizoma Atractylodis Macrocephalae, Arillus Longan, Radix Rehmanniae, Flos Chrysanthemi Indici, Cortex Phellodendri, Radix Notoginseng, Rhizoma Polygoni Cuspidati, Pericarpium Citri Reticulatae Viride, Fructus Gardeniae, is used tumbling-box type medicine-washing machine to clean, and scavenging period is controlled at 3-5 minute, avoids drug effect to run off;
The step of B, demulcen: the Chinese medicinal components that steps A is cleaned up, use water injection type medicine processing device to carry out demulcen operation, demulcen makes the plant cell imbibition of dehydration, for abstraction process creates conditions;
C, above-mentioned component add 10 times of weight amount ethanol, heating and refluxing extraction 3 times, and each 2 hours, 3 extracting solution are merged, decompression recycling ethanol, and to be concentrated into liquor strength be 0.5g crude drug/mL, after sucking filtration, when the relative density of filtrate is 20 ℃ 1.08; The macroporous adsorptive resins that described filtrate flow is 10L through volume, use afterwards deionized water or the distilled water eluting of 10 times of resin column volumes, use again 95% ethanol elution of 5 times of resin column volumes, collect ethanol elution, remove alcohol solvent, obtain Chinese medicinal powder, then after 80 order sieve, standby after ultraviolet sterilization;
The step of D, Stichopus japonicus deep processing: fresh and alive sea cucumbers, along abdominal part from first to last complete section open, gill, impurity is cleaned up; Then carry out lyophilization, cryogenic temperature is-20 ~-25 ℃, and vacuum is 5-15Pa, and quick freezing 2-3h puts into pulverizer by the Stichopus japonicus after lyophilization, pulverizes 10-30min, crosses 60 mesh sieves, obtains thick Stichopus japonicus powder; Stichopus japonicus coarse powder is carried out to micronizing by jet mill, and time 2-3h, obtains ultra micro Stichopus japonicus powder; Then ultra micro Stichopus japonicus powder is carried out to nanorize pulverizing by high speed shear ultrafine crusher, grinding time is 3-5h;
In container, add pure water, Stichopus japonicus powder after nanorize is pulverized with water with 1: the dissolving of 5-10 mass ratio, obtain sea cucumber milk, take the compound protease of Stichopus japonicus weight 0.3-0.4%, compound protease is the mixture of pepsic bromelain stomach, protease: the mass ratio=2:1 of bromelain, after using pure water that compound protease is dissolved, together with sea cucumber milk, put into enzymatic vessel, standing 1-2min in the microwave environment that is 500-1000w in intensity, carry out the operation of microwave enzymolysis, after enzymolysis completes, by enzymolysis solution rapidly degree of intensification to 90 ℃ of enzyme denaturing 10-30min, complete after the deactivation of enzyme, enzymatic vessel is stopped to heating, enzymolysis solution is cooled to rapidly to room temperature, enzymatic vessel purified rinse water, flushing liquor is put into enzymolysis solution, enzymolysis solution after cooling is first used to the centrifugal 20min of generic centrifuge, filter, get filtrate, the centrifugal 20min of low temperature ultrahigh speed, filters, and obtains filtrate, by filtrate by nanofiltration with except freshen, residue is crossed 100 mesh sieves, obtains sea cucumber extract,
E, prepare the step of capsule: step C gained Chinese medicinal powder is joined in the sea cucumber extract of step D gained to Chinese medicinal powder: the weight ratio of sea cucumber extract is 1-1.2:1-1.5; After mix homogeneously, add additional material, in the pasty state, compression molding, is dried to obtain chewable tablet to the mixture obtaining.
eating effect comparison of the present invention:
50 white mice of take are laboratory animal, by the long 3mm of rear thigh incised wound of 50 white mice, the wound of dark 1mm, respectively smear mercurochrome and wrap gauze, and then every 10 is one group,
First group is the present invention of experimental group feeding,
Second group as a control group 1, do not feed.
The 3rd group as a control group 2, feeding step C gained Chinese medicinal powder.
The 3rd group as a control group 3, feeding contains chitinous soft gelatin capsule.
The 4th group as a control group 4, the sea cucumber extract of feeding step D gained.
The 5th group as a control group 5, direct feeding Stichopus japonicus.
After 3 weeks, wound is carried out to gross specimen observation, biomechanics test, gross specimen observed result: experimental group wound heals completely, falls crust naturally;
Matched group 1, not healing.Heal completely compared with 12 days experimental group evenings
Matched group 2, healing, does not fall crust substantially; Heal completely compared with 5 days experimental group evenings
Matched group 3, healing, does not fall crust substantially; Heal completely compared with 7 days experimental group evenings
To group, according to 4, healing, does not fall crust substantially; Heal completely compared with 6 days experimental group evenings
Matched group 5, healing, healed completely compared with 10 days experimental group evenings
Biomechanics test result is as following table:
As can be seen from the above table, the present invention has the effect of quickly-healing wound.
immunity comparison:
Select 10 white mice feeding tradition Stichopus japonicus tablets as a control group,
Select 10 white mice feedings the present invention group as a comparison.
Be compared as follows:
Wherein, the absorption of comparable group calcium and mineral is fast, and propagation bacillus bifidus, lactobacillus number is many, and the index of blood fat, blood glucose, cholesterol regulating is low compared with matched group.3-5 is placed in dark environment and the environment that is exposed to the sun repeatedly in day, the matched group probability of catching an illness is large, so comparable group immunity is strong.
In the present invention, Chinese medicine composition is for the pharmacy mechanism evidence that promotes wound healing:
1, lower the expression of HIF-1 alpha levels, rise VEGF, histiocyte can be induced and be produced HIF-1 Hypoxia Inducible Factor-1 (hypoxia-inducible factor-1 under hypoxic-ischemic environment, HIF-1, comprise two kinds of HIF-1 α and HIF-1 β), wherein HIF-1 α can modulating vascular endothelial cell growth factor (ECGF) (vascular endothelial growth factor, VEGF), the expression of endothelin-1, erythropoietin etc., promote formation and the vascular remodeling of new vessels, thereby start wound repair mechanism.By observing benefiting qi and removing blood stasis Chinese medicine, promote the impact of diabetic skin ulcer Rats Exposed To Hypoxia inducible factor-1 and vascular endothelial cell growth factor, result shows that benefiting qi and removing blood stasis Chinese medicine can be by lowering the expression of HIF-1 α, the expression of rise VEGF, improve ischemia anaerobic condition, impel angiogenesis, thus wound healing.
2, the receptor RTK activity in enhancing wound healing is in the process of wound healing, somatomedin plays an important role, somatomedin is by receptor tyrosine kinase (receptor tyrosine kinase, RTK) mediated cell external stimulus signal, the functions such as the propagation of regulating cell, differentiation.Observe the impact of Chinese medicine on soft-tissue trauma healing receptor tyrosine kinase activity, result shows that Chinese medicine can strengthen the RTK activity in soft-tissue trauma healing.
3, promote the propagation of new capillary vessel, promote granulation tissue growth to improve the regeneration of permeability and the blood vessel of wound surface blood vessel, can improve the blood confession of affected part, promote granulation tissue growth, accelerate the immediate union of wound surface.Herbal mixture promotes the experimentation of rabbit skin wound healing, and result shows that this herbal mixture has significant effect in wound healing, can promote wound reconstructing blood vessel, reduces the infiltration of inflammatory cell, accelerates collagen fiber hypertrophy and forms cicatrix, prevents wound infection.
4, promote rising transforming growth factor-beta 1 (the transforming growth factor-β 1 that TGF-β 1 expresses, TGF-β 1) Main Function is growth and the differentiation that regulates cell, synthetic and the apoptosis of inducing cell epimatrix, thereby the healing of promotion wound.By the observation to transforming growth factor-beta and wound healing, result shows that TGF-β 1 expresses and raises at early metaphase, to promoting the synthetic collagen protein of fibroblast, Dan Baiduotang proteoglycan PG, fiber connexin and integral protein, strengthening migration of epithelial cells and fibroblast synthetic cell epimatrix has key effect, is an importance of its wound healing.
Proportioning of the present invention is simple, prescription collocation rationally, speed of wound healing is reconciled, increased to Promote immunity, be specially: the present invention be take Stichopus japonicus as basestocks, add therein blood circulation promoting and blood stasis dispelling, hemostasis and pain-relieving, promoting of the circulation of QI and removing the obstruction in the collaterals, the corresponding Chinese medicinal components of clearing heat and moistening dryness, to improve speed of wound healing, in addition, further add chitin, Stichopus japonicus effect, herbal function are combined with chitin effect, and preparation becomes chewable tablet to be used, and all effect is remarkable in the speed for the treatment of wound for more independent treatment by Chinese herbs, simple Stichopus japonicus tonic or chitin soft gelatin capsule.
Claims (4)
1. a Stichopus japonicus chewable tablet, is characterized in that, comprises according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 30-50 part, Cacumen Platycladi 20-40 part, Folium Artemisiae Argyi 20-40 part, Radix Salviae Miltiorrhizae 20-40 part, Sanguis Draxonis 10-30 part, Rhizoma Atractylodis Macrocephalae 10-30 part, Arillus Longan 10-30 part, Radix Rehmanniae 10-30 part, Flos Chrysanthemi Indici 10-30 part, Cortex Phellodendri 10-30 part, Radix Notoginseng 10-30 part, Rhizoma Polygoni Cuspidati 10-30 part, Pericarpium Citri Reticulatae Viride 10-30 part, Fructus Gardeniae 10-30 part
Basestocks: Stichopus japonicus 300-500 part;
Additional material: chitin 3-6 part, starch 10-20 part, dextrin 5-10 part, mannitol 3-6 part, sweeting agent 1-4 part, microcrystalline Cellulose 1-4 part.
2. Stichopus japonicus chewable tablet according to claim 1, is characterized in that, comprises according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 30-40 part, Cacumen Platycladi 20-30 part, Folium Artemisiae Argyi 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Sanguis Draxonis 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Arillus Longan 10-20 part, Radix Rehmanniae 10-20 part, Flos Chrysanthemi Indici 10-20 part, Cortex Phellodendri 10-20 part, Radix Notoginseng 10-20 part, Rhizoma Polygoni Cuspidati 10-20 part, Pericarpium Citri Reticulatae Viride 10-20 part, Fructus Gardeniae 10-20 part
Basestocks: Stichopus japonicus 300-400 part;
Additional material: chitin 3-5 part, starch 10-15 part, dextrin 5-8 part, mannitol 3-5 part, sweeting agent 1-3 part, microcrystalline Cellulose 1-3 part.
3. Stichopus japonicus chewable tablet according to claim 1, is characterized in that, comprises according to the following active component of parts by weight configuration:
Middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 40-50 part, Cacumen Platycladi 30-40 part, Folium Artemisiae Argyi 30-40 part, Radix Salviae Miltiorrhizae 30-40 part, Sanguis Draxonis 20-30 part, Rhizoma Atractylodis Macrocephalae 20-30 part, Arillus Longan 20-30 part, Radix Rehmanniae 20-30 part, Flos Chrysanthemi Indici 20-30 part, Cortex Phellodendri 20-30 part, Radix Notoginseng 20-30 part, Rhizoma Polygoni Cuspidati 20-30 part, Pericarpium Citri Reticulatae Viride 20-30 part, Fructus Gardeniae 20-30 part
Basestocks: Stichopus japonicus 400-500 part;
Additional material: chitin 4-6 part, starch 15-20 part, dextrin 8-10 part, mannitol 4-6 part, sweeting agent 2-4 part, microcrystalline Cellulose 2-4 part.
4. Stichopus japonicus chewable tablet according to claim 1, is characterized in that, comprises according to the following active component of parts by weight configuration:
Middle spice: middle spice: Pseudobulbus Bletillae (Rhizoma Bletillae) 35-45 part, Cacumen Platycladi 25-35 part, Folium Artemisiae Argyi 25-35 part, Radix Salviae Miltiorrhizae 25-35 part, Sanguis Draxonis 15-25 part, Rhizoma Atractylodis Macrocephalae 15-25 part, Arillus Longan 15-25 part, Radix Rehmanniae 15-25 part, Flos Chrysanthemi Indici 15-25 part, Cortex Phellodendri 15-25 part, Radix Notoginseng 15-25 part, Rhizoma Polygoni Cuspidati 15-25 part, Pericarpium Citri Reticulatae Viride 15-25 part, Fructus Gardeniae 15-25 part
Basestocks: Stichopus japonicus 350-450 part;
Additional material: chitin 4-5 part, starch 12-18 part, dextrin 6-9 part, mannitol 2-5 part, sweeting agent 2-3 part, microcrystalline Cellulose 2-3 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310491365.4A CN103585456A (en) | 2013-10-20 | 2013-10-20 | Sea cucumber chewable tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310491365.4A CN103585456A (en) | 2013-10-20 | 2013-10-20 | Sea cucumber chewable tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103585456A true CN103585456A (en) | 2014-02-19 |
Family
ID=50075909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310491365.4A Pending CN103585456A (en) | 2013-10-20 | 2013-10-20 | Sea cucumber chewable tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103585456A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107568642A (en) * | 2017-09-29 | 2018-01-12 | 句容市空凤来仪商贸有限公司 | A kind of colored glue chewable tablets and preparation method thereof |
| CN109567070A (en) * | 2018-12-12 | 2019-04-05 | 海南热带海洋学院 | A kind of acerola concentrate sea cucumber composite chewable tablet and preparation method thereof |
-
2013
- 2013-10-20 CN CN201310491365.4A patent/CN103585456A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107568642A (en) * | 2017-09-29 | 2018-01-12 | 句容市空凤来仪商贸有限公司 | A kind of colored glue chewable tablets and preparation method thereof |
| CN109567070A (en) * | 2018-12-12 | 2019-04-05 | 海南热带海洋学院 | A kind of acerola concentrate sea cucumber composite chewable tablet and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103610035A (en) | Preparation method for sea cucumber nutritional oral liquid | |
| CN103610072A (en) | Preparation method for blood-sugar-reducing sea cucumber oral liquid | |
| CN103598593A (en) | Manufacturing method of sea cucumber nutrient tablets | |
| CN103598623A (en) | Manufacturing method of sea cucumber tablets | |
| CN103610077A (en) | Sea cucumber capsule | |
| CN103585456A (en) | Sea cucumber chewable tablet | |
| CN103599468A (en) | Manufacturing method of sea cucumber tablet for adjusting immunity | |
| CN103599366A (en) | Manufacturing method of sea cucumber chewing tablets | |
| CN103599469A (en) | Sea cucumber chewing tablet capable of increasing wound healing speed and application method thereof | |
| CN103598578A (en) | Sea cucumber chewing tablet and application method thereof | |
| CN103598622A (en) | Sea cucumber nutrient tablet and application method thereof | |
| CN103598576A (en) | Manufacturing method of sea cucumber chewing tablet capable of increasing wound healing speed | |
| CN103610069A (en) | Blood-sugar-reducing sea cucumber oral liquid | |
| CN103598625A (en) | Sea cucumber tablet | |
| CN103610068A (en) | Preparation method for blood-fat-reducing sea cucumber oral liquid | |
| CN103610112A (en) | Immunity-enhancing sea cucumber oral liquid and application method thereof | |
| CN103599470A (en) | Sea cucumber tablet for adjusting immunity | |
| CN103598575A (en) | Sea cucumber chewing tablet capable of increasing wound healing speed | |
| CN103598577A (en) | Sea cucumber nutrient tablet | |
| CN107596277A (en) | A kind of sea cucumber chewable tablet for increasing speed of wound healing | |
| CN103598624A (en) | Sea cucumber tablet and application method thereof | |
| CN103610073A (en) | Sea cucumber oral liquid and application method thereof | |
| CN103611058A (en) | Sea cucumber capsule and application method thereof | |
| CN103610117A (en) | Sea cucumber nutritional oral liquid | |
| CN103610071A (en) | Preparation method for blood-pressure-reducing sea cucumber oral liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140219 |